The scope of onychomycosis: epidemiology and clinical features

Eckart Haneke, Diane Roseeuw

International Journal of Dermatology · 1999 · 142 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

The preliminary results of the Achilles Project data from Europe and East Asia were used to permit a more accurate estimate of the epidemiology of onychomycosis, the leading clinical features, and the most important predisposing factors of fungal foot infections. The Achilles foot-screening project is a scientific project to investigate the prevalence and seriousness of foot problems across Europe and East Asia. This project can be divided into two groups: a survey consisting of a clinical examination of the feet, and a study with a mycologic examination if an infection of the feet was suspected. Compared to other epidemiologic studies, a considerably larger population was screened; 80 396 subjects were examined: 13 695 in the European Study, 22 760 in the European Survey and 43 914 in the East Asian Survey. The clinical diagnosis of the physician was confirmed by a mycologic examination in the European study. Microscopic examination and culture were performed in order to identify the pathogen causing the fungal infection because this information is essential for the physician to choose the optimal treatment. The prevalence of foot diseases and, more specifically, of fungal infection is higher than imagined in this kind of population, i.e. patients who visit their physician for other problems than those with their feet. Dermatophytes were the most prevalent pathogens, especially Tricophyton rubrum, but yeasts like Candida albicans were also possible infectious agents. Non-dermatophyte molds like Aspergillus spp. were isolated as pathogens, frequently in mixed infections. Some patients have a higher risk of contracting a fungal infection like onychomycosis. These predisposing factors were vascular diseases, atopy, obesity, diabetes mellitus, and sports. The prevalence of onychomycosis increases with advancing age, but sex-dependency has not yet been proved. Compared to other epidemiological studies, the prevalence of onychomycosis as found in the Achilles study is much higher. The need for a diagnosis by a physician is shown and, above all, a mycological examination is needed to give a confirmation of this clinical diagnosis. From the preliminary results it can be concluded that physicians have to take a more active approach to foot health. In the past, epidemiologic studies concerning fungal infections like tinea pedis and onychomycosis were performed in small and specific population groups such as school children, subjects visiting swimming baths, 1–3 subjects with specific occupations, like coal-miners 4 or men under military service, 5,6 or patients with underlying diseases like diabetes. 7 Moreover, patients often had to diagnose the condition themselves. The first epidemiological study in a general population in the United Kingdom 5 was a computer omnibus survey where each respondent was asked a series of questions and was shown some photographs in order to perform a self-diagnosis. The same type of study, i.e. with a self-diagnosis, was performed in Spain. 8 This method has the common disadvantage of questionnaire studies, giving an underestimation of the prevalence of fungal infections. Studies with mycologic examination were also performed, but these were studies on small populations and were country-specific, e.g. in a dermatology clinic in north–eastern Ohio (1000 patients), and in patients visiting a dermatologist’s office in Ontario (2001 patients), Finland (800 patients), and in China (232 patients). 6,9–11 The prevalence of onychomycosis seems to differ across the world because of socioeconomic and cultural factors. 12 It was generally accepted that the overall prevalence of fungal infections like onychomycosis was estimated to be between 3 and 5%, but somewhat higher in certain occupational communities and in patients over 40 years of age. 5,9,10,13 Baran et al. 14 divided onychomycosis into five clinical types: 1 distal–lateral subungual onychomycosis affecting the nail bed epithelium and from there the undersurface of the nail plate; 2 white superficial onychomycosis affecting the surface of the nail plate as small chalky-white spots or streaks; 3 proximal subungual onychomycosis starting from the ventral aspect of the proximal nail fold to invade the proximal area of the nail plate and eventually the matrix; 4 endonyx onychomycosis with primary and almost exclusive fungal attack of the nail plate; and 5 total dystrophic onychomycosis developing primarily in chronic mucocutaneous candidiasis and secondarily from any of the former types. Total dystrophic onychomycosis affects the nail bed, matrix, and the entire thickness of the nail plate. Each type of onychomycosis has characteristic features including discoloration, subungual hyperkeratosis, thickening of the nail plate, detachment of the nail from the nail bed (onycholysis), brittle, damaged nails, inflammation of the nail bed which usually goes unnoticed, and sometimes paronychia. In particular, discoloration and hyperkeratosis are frequent signs in the clinical diagnosis of onychomycosis. A variety of fungal organisms can cause onychomycosis and tinea pedis. Frequently, onychomycosis is a secondary infection because of spread of the fungus from the toe clefts to the nail. The cause of infection of the skin and the nails is therefore the same in most cases. 15 Fungi are spread worldwide, but the different species have their own characteristic occurrence in certain geographic areas. 12,13 Dermatophytes are the most common pathogens for onychomycosis, with Trichophyton rubrum as the most frequently isolated organism, followed by T. mentagrophytes and Epidermophyton floccosum. These dermatophytes mostly cause superficial infections, distal subungual onychomycosis, and white superficial onychomycosis. Proximal subungual onychomycosis is caused by a pre-existing T. rubrum infection of the skin (tinea pedis). 11,12,14–16 Yeasts can also cause onychomycosis; these are most commonly Candida albicans, but less frequently C. parapsilosis and other Candida spp. Yeasts can be seen as saprophytes that are not able to damage the nail plate, but invade an already damaged nail, except when immunosupression is present. The type of onychomycosis caused by Candida infection is chronic mucocutaneous candidiasis. 11,12,14 Non-dermatophytes like Aspergillus spp., Scopulariopsis brevicaulis, Scytalidium dimidiatum, and Fusarium spp. are found to cause onychomycosis in a limited number of cases. Most of these species are opportunists that invade altered keratin, frequently in combination with dermatophyte infections. 11,12,15 Each fungal species has certain host specificity, but the situation is constantly changing. Some fungi infect only humans (e.g. T. rubrum), whereas others cause infections in a wide range of mammalian species (e.g. T. mentagrophytes). Most species also exhibit a preference for some part of the body. Candida sp. causes a large part of the fungal infections of the fingernails. Occasionally mixed infections are found with different combinations of pathogens: two dermatophytes may coexist, nondermatophyte molds can overgrow a dermatophyte infection and yeasts are found in combination with dermatophytes and other molds. 12,14,15 When choosing a treatment for onychomycosis, the type of infectious agent is an important criterion. The aim of the large-scale Achilles project was to obtain a figure for the overall prevalence of foot diseases, like fungal infections, across Europe and East Asia, and to increase the awareness of foot pathologies for physicians as well as for patients; patients sometimes fail to raise their foot problem at an appointment with a physician because the years of neglect will reflect badly on them. Because of their ignorance of foot problems, patients do not seek treatment in time and the condition often becomes very serious, affecting quality of life (itching, pain, discomfort in walking, embarrassment, limitations in work and other activities). This makes the disease more difficult to treat and a longer treatment duration is needed. People should be educated that foot problems are not due to poor personal hygiene, but that underlying causes may be related to a variety of predisposing factors which mean that some people are more likely to contract a foot problem like a fungal infection. Moreover, both physicians and patients should be aware of the existence of effective therapy like the oral antifungal agents itraconazole, fluconazole and terbinafine. The Achilles foot-screening project is a scientific project consisting of a Survey, conducted in Europe by general practitioners and in East Asia by dermatologists, and a Study conducted only by dermatologists in Europe. In the Study, a mycological examination was performed when an infection of the feet or nails was suspected. Patients of a general population, visiting their physician not only for foot problems, were asked for permission for an examination of their feet. There was no patient selection for sex, age, and medical complaints. The Survey was conducted by general practitioners in 22 760 European patients from Belgium, The Netherlands, Luxembourg, Switzerland, Hungary, Great Britain, and Poland, and by dermatologists in East Asia in 43 914 patients from China, South Korea, and Taiwan. The mycological examination consisted of the identification of the fungus in potassium hydroxide preparation (KOH microscopy) and a culture growth of the fungus in a suitable medium. Staats et al. 15 stated that, for dermatophyte infections, microscopic examination is more sensitive than culture identification because some dermatophytes are hard to grow, but yet culture growth is needed in order to identify the type of dermatophyte. For Candida infections, microscopic examination does not always identify the pathogen, whereas culture growth defines the infection most of the time. It is therefore necessary that both types of examination need to be executed so that all types of pathogens can be detected. Histopathology is often very helpful. 12,14 In the Achilles Study in Europe, both KOH microscopy and cultures were performed. Each type of onychomycosis demands a specific well-selected sample. 15,16 In the Achilles project, samples could be obtained by scraping, cutting or curettage. Prevalence was defined as the number of cases divided by the number of patients in the studied population. In Europe, 70% of the screened patients were adults (18–65 years of age), 23% were elderly (> 65 years), and 6% were children (< 18 years). Fifty-nine percent of the patients were women. In East Asia, an even higher proportion of the patients was between 18 and 65 years of age (83%) and 52% were women. In the Study, 13 695 patients in Europe consulted a dermatologist and received a mycological examination if there was suspicion of some kind of foot infection. Twelve percent were children, 70% were adults and 18% were elderly. Fifty-eight percent of the screened patients were women. The dermatologists of the Achilles Study diagnosed foot pathologies in 7993 of 13 695 patients from different countries in Europe (58%). General practitioners found that 12 842 of the 22 760 patients had affected feet (56%) in Europe. In the East Asian Survey, in 62% of the cases the physician suspected some kind of foot pathology (26 615 of 42 936). These foot pathologies could have been fungal infections of the skin and/or nails, malformations of the feet, metatarsal corns, psoriasis, warts, eczema, ulcers, or gangrene/necrosis ( Table 1). Comparison of the prevalence of the different diseases showed that fungal infection, and especially tinea pedis and onychomycosis, was the most common complaint in the European as well as in the East Asian screened population according to both the Survey and the Study. The prevalence of tinea pedis seemed higher in East Asia (37% of the total and 61% of the affected population) than in Europe (24% of the total and 42% of the affected population). Moreover, the European preliminary results from both the Study and the Survey showed a small difference between the occurrence of onychomycosis (23% and 26% in the total population of the Study and the Survey, respectively; 40% and 46%, respectively in the affected population) and tinea pedis (22% and 24% in the total population of the Study and Survey, respectively; 38% and 42%, respectively in the affected population) with the highest prevalence for onychomycosis. In East Asia, however, the prevalence of tinea pedis was much higher than the prevalence of onychomycosis ( Table 1). If the dermatologist clinically diagnosed foot pathology, onychomycosis was assumed to be present in 40% of the patients in Europe. General practitioners made a clinical diagnosis of 46% of onychomycosis cases in the European countries, while in East Asia 36% of the patients had signs of onychomycosis ( Table 1). The clinical diagnosis of onychomycosis is not easy because other pathologies like psoriasis, eczema, etc., may mimic the signs of fungal infections. Therefore, a mycologic examination should be performed. In the European study, 86% of the clinical diagnoses of onychomycosis were confirmed by mycology. Certain populations are more susceptible to fungal infections because of some predisposing factors. Appearance of onychomycosis is possibly related to geography, ethnicity, social class, certain occupations, genetics, other diseases, etc. 3,17,18 The preliminary results of the Achilles project both in Europe and in East Asia showed that the most common predisposing factors of foot diseases were vascular diseases, obesity, atopy, sports, diabetes mellitus, osteoarticular pathology, and dermatologic pathology ( Fig. 1). Prevalence of the most frequently reported predisposing factors for foot diseases in the population with affected feet for Europe (Study and Survey) and East Asia (Survey) The prevalence of onychomycosis increases with advancing age. 12,17 Patients over 40 years of age have a higher risk of developing onychomycosis. These findings are reconfirmed by the Achilles data ( Fig. 2). Prevalence of clinically diagnosed onychomycosis increases with advancing age. Data from the affected population from Europe (Study and Survey) and East Asia (Survey) The sex-dependency of onychomycosis is still a topic of discussion. The Achilles data of the European Study and Survey report a higher prevalence of clinically diagnosed onychomycosis in the men of the total screened population (26% and 27% in the Study and Survey, respectively) compared to the women (21% and 25%), while in East Asia more women suffered from onychomycosis (43%) than men (39%). The clinical diagnosis of onychomycosis is not so easy to make, because psoriasis and other disorders may mimic the clinical signs. Therefore it is necessary to perform a mycologic examination if the physician suspects an infection like onychomycosis. Eighty percent of the patients with mycologically proven onychomycosis in the screened population of the European Study had signs of discoloration and/or hyperkeratosis. Almost 5 of 10 patients showed onycholysis ( Tables 2 and 3). The diagnosis of fungal infections should be sustained by a mycological examination. In the Achilles Study in Europe, 86% of the clinically diagnosed onychomycoses were mycologically confirmed. The Achilles Study in Europe revealed that physicians used curette or scraping as a sampling method in almost half of the patients and that only a small percentage of the patients were examined by clipping of the nails. The Achilles Study in Europe produced similar results to those found in most epidemiological studies. In both tinea pedis and onychomycosis the most prevalent isolated pathogens were dermatophytes (68% in both skin and nails), with T. rubrum being the most prevalent (53% in nails and 48% in skin), followed by T. mentagrophytes/interdigitale (13% in nails and 18% in skin). Yeasts caused an infection of the nails in 11% of cases (166/1569), with C. albicans being the most prevalent (8%). For tinea pedis, yeasts caused 14% of cases, and in 12% of the subjects C. albicans was found. Non-dermatophyte molds were responsible for 11% of the onychomycosis cases (169/1569) and for 7% of the tinea pedis cases. The most frequently isolated molds were Aspergillus spp. (4% in nails, 3% in skin) and S. brevicaulis (3% in nails, 0.4% in skin)( Table 4). The Achilles project screened patients that visited their doctor for any kind of problem. In East Asia, a survey was carried out, i.e. dermatologists performed a clinical examination. In Europe, in addition to the Survey, a Study was performed where patients received a mycological examination when a fungal infection was suspected. From the preliminary results of the Achilles project (Study as well as Survey), it can be concluded that patients as well as physicians should be aware of the problems that foot pathologies provoke. Fungal infections should be prevented, or patients screened early enough in order to stop further development into serious infections. Physicians should approach foot problems more actively, especially in those patients who are at a higher risk of experiencing problems. Patients at risk have to be informed about the possibilities of prevention and the need to treat the fungal infections in time. Comparison with other epidemiologic studies revealed that the prevalence of fungal infections is much higher than anticipated in the same population groups. Two out of 10 European patients visiting a doctor showed signs of onychomycosis. If the physician reported foot pathology, this figure rose to four of 10 patients. Although prevalence of predisposing factors was much lower in East Asia, the same prevalence of onychomycosis and a higher proportion of tinea pedis were found compared to the European Survey data. Other epidemiologic studies also found conflicting results. In some studies, women had higher prevalence of onychomycosis, 8 in others there was no difference between the sexes. 5 Because of the different pathogens found, an ideal antifungal agent should have a broad spectrum of activity that includes all infectious dermatophytes, molds and yeasts. It should have a good bioavailability and the capacity to be incorporated into the nail matrix. The goal is to achieve high cure rates and low relapse rates with short treatment durations, and adverse events limited to a few nonserious reactions. Moreover there should be good patient compliance. 19

References

13